BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Icsel C, Yilmaz VT, Aygun M, Erkisa M, Ulukaya E. Novel 5-fluorouracil complexes of Zn(II) with pyridine-based ligands as potential anticancer agents. Dalton Trans 2022;51:5208-17. [PMID: 35275157 DOI: 10.1039/d1dt04070g] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Ichimaru Y, Kato K, Nakatani R, Sugiura K, Mizutani H, Kinoshita-kikuta E, Koike T, Jin W, Imai M, Kurosaki H. Characterization of Zinc(II) Complex of 1,4,7,10-Tetrazacyclododecane and Deprotonated 5-Fluorouracil (FU) in Crystalline/Solution States and Evaluation of Anticancer Activity: Approach for Improving the Anticancer Activity of FU. Inorganic Chemistry Communications 2022. [DOI: 10.1016/j.inoche.2022.110221] [Reference Citation Analysis]
2 Zhou Z, Du LQ, Huang XM, Zhu LG, Wei QC, Qin QP, Bian H. Novel glycosylation zinc(II)-cryptolepine complexes perturb mitophagy pathways and trigger cancer cell apoptosis and autophagy in SK-OV-3/DDP cells. Eur J Med Chem 2022;243:114743. [PMID: 36116236 DOI: 10.1016/j.ejmech.2022.114743] [Reference Citation Analysis]
3 Zhang S, Wang Z, Tan H. Novel zinc(II)−curcumin molecular probes bearing berberine and jatrorrhizine derivatives as potential mitochondria-targeting anti-neoplastic drugs. European Journal of Medicinal Chemistry 2022. [DOI: 10.1016/j.ejmech.2022.114736] [Reference Citation Analysis]